中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2015年
5期
580-583
,共4页
王寿平%陈晓彤%詹鸿%彭书崚
王壽平%陳曉彤%詹鴻%彭書崚
왕수평%진효동%첨홍%팽서릉
麻醉药,吸入%麻醉,全身%婴儿%腹腔镜检查%压力支持通气
痳醉藥,吸入%痳醉,全身%嬰兒%腹腔鏡檢查%壓力支持通氣
마취약,흡입%마취,전신%영인%복강경검사%압력지지통기
Anesthetics,inhalation%Anesthesia,general%Infant%Laparoscopy%Pressure support ventilation
目的:评价压力支持通气( PSV)用于七氟醚麻醉下婴儿腹腔镜疝修补术的效果。方法择期行腹腔镜疝修补术患儿30例,年龄9个月~1岁,性别不限,体重8.0~11.5 kg,ASA分级Ⅰ级。采用随机数字表法,将患儿分为3组( n=10):压力控制通气( PCV)用于肌松药复合低浓度七氟醚麻醉组( PCV1组)、PCV用于高浓度七氟醚麻醉组( PCV2组)和 PSV 用于低浓度七氟醚麻醉组(PSV组)。麻醉诱导:吸入4%~6%七氟醚,静脉注射芬太尼2μg∕kg和琥珀胆碱1.5 mg∕kg,气管插管后行机械通气。 PCV1组和PCV2组采用PCV模式;PSV组无自主呼吸时采用PCV模式,有自主呼吸时采用PSV模式。麻醉维持:PCV1组维持七氟醚呼气末浓度2.5%~3.0%,间断静脉注射顺苯磺酸阿曲库铵0.1 mg∕kg;PCV2组维持七氟醚呼气末浓度3.5%~4.0%;PSV 组维持七氟醚呼气末浓度2.5%~3.0%,在置入气腹针前静脉注射琥珀胆碱1.0 mg∕kg;PCV1组和PSV组维持Narcotrend指数值50~60,PCV2组维持 Narcotrend 指数值37~45。分别于麻醉诱导前(基础水平)、气腹开始、气腹5 min、气腹10 min、停止气腹、术毕和拔除气管导管时记录HR和MAP ,记录气管导管拔除时间。结果3组麻醉期间SpO2均为100%,麻醉恢复期SpO2均>95%。与基础值比较,PCV1组和PCV2组拔除气管导管时 HR 增快,MAP 升高(P<0.05),PSV 组各时点 HR 和 MAP 差异无统计学意义(P>0.05)。 PCV1组、PCV2组和PSV组气管导管拔除时间分别为30.3±5.4、18.4±4.3、(4.1±1.2) min;与PCV1组和PCV2组比较,PSV组气管导管拔除时间缩短( P<0.05)。结论 PSV用于七氟醚麻醉下婴儿腹腔镜疝修补术时,可保证有效通气,麻醉恢复迅速,且拔除气管导管时无心血管反应。
目的:評價壓力支持通氣( PSV)用于七氟醚痳醉下嬰兒腹腔鏡疝脩補術的效果。方法擇期行腹腔鏡疝脩補術患兒30例,年齡9箇月~1歲,性彆不限,體重8.0~11.5 kg,ASA分級Ⅰ級。採用隨機數字錶法,將患兒分為3組( n=10):壓力控製通氣( PCV)用于肌鬆藥複閤低濃度七氟醚痳醉組( PCV1組)、PCV用于高濃度七氟醚痳醉組( PCV2組)和 PSV 用于低濃度七氟醚痳醉組(PSV組)。痳醉誘導:吸入4%~6%七氟醚,靜脈註射芬太尼2μg∕kg和琥珀膽堿1.5 mg∕kg,氣管插管後行機械通氣。 PCV1組和PCV2組採用PCV模式;PSV組無自主呼吸時採用PCV模式,有自主呼吸時採用PSV模式。痳醉維持:PCV1組維持七氟醚呼氣末濃度2.5%~3.0%,間斷靜脈註射順苯磺痠阿麯庫銨0.1 mg∕kg;PCV2組維持七氟醚呼氣末濃度3.5%~4.0%;PSV 組維持七氟醚呼氣末濃度2.5%~3.0%,在置入氣腹針前靜脈註射琥珀膽堿1.0 mg∕kg;PCV1組和PSV組維持Narcotrend指數值50~60,PCV2組維持 Narcotrend 指數值37~45。分彆于痳醉誘導前(基礎水平)、氣腹開始、氣腹5 min、氣腹10 min、停止氣腹、術畢和拔除氣管導管時記錄HR和MAP ,記錄氣管導管拔除時間。結果3組痳醉期間SpO2均為100%,痳醉恢複期SpO2均>95%。與基礎值比較,PCV1組和PCV2組拔除氣管導管時 HR 增快,MAP 升高(P<0.05),PSV 組各時點 HR 和 MAP 差異無統計學意義(P>0.05)。 PCV1組、PCV2組和PSV組氣管導管拔除時間分彆為30.3±5.4、18.4±4.3、(4.1±1.2) min;與PCV1組和PCV2組比較,PSV組氣管導管拔除時間縮短( P<0.05)。結論 PSV用于七氟醚痳醉下嬰兒腹腔鏡疝脩補術時,可保證有效通氣,痳醉恢複迅速,且拔除氣管導管時無心血管反應。
목적:평개압력지지통기( PSV)용우칠불미마취하영인복강경산수보술적효과。방법택기행복강경산수보술환인30례,년령9개월~1세,성별불한,체중8.0~11.5 kg,ASA분급Ⅰ급。채용수궤수자표법,장환인분위3조( n=10):압력공제통기( PCV)용우기송약복합저농도칠불미마취조( PCV1조)、PCV용우고농도칠불미마취조( PCV2조)화 PSV 용우저농도칠불미마취조(PSV조)。마취유도:흡입4%~6%칠불미,정맥주사분태니2μg∕kg화호박담감1.5 mg∕kg,기관삽관후행궤계통기。 PCV1조화PCV2조채용PCV모식;PSV조무자주호흡시채용PCV모식,유자주호흡시채용PSV모식。마취유지:PCV1조유지칠불미호기말농도2.5%~3.0%,간단정맥주사순분광산아곡고안0.1 mg∕kg;PCV2조유지칠불미호기말농도3.5%~4.0%;PSV 조유지칠불미호기말농도2.5%~3.0%,재치입기복침전정맥주사호박담감1.0 mg∕kg;PCV1조화PSV조유지Narcotrend지수치50~60,PCV2조유지 Narcotrend 지수치37~45。분별우마취유도전(기출수평)、기복개시、기복5 min、기복10 min、정지기복、술필화발제기관도관시기록HR화MAP ,기록기관도관발제시간。결과3조마취기간SpO2균위100%,마취회복기SpO2균>95%。여기출치비교,PCV1조화PCV2조발제기관도관시 HR 증쾌,MAP 승고(P<0.05),PSV 조각시점 HR 화 MAP 차이무통계학의의(P>0.05)。 PCV1조、PCV2조화PSV조기관도관발제시간분별위30.3±5.4、18.4±4.3、(4.1±1.2) min;여PCV1조화PCV2조비교,PSV조기관도관발제시간축단( P<0.05)。결론 PSV용우칠불미마취하영인복강경산수보술시,가보증유효통기,마취회복신속,차발제기관도관시무심혈관반응。
Objective To evaluate the efficacy of pressure support ventilation ( PSV ) in the infants undergoing laparoscopic hernia repair under sevoflurane anesthesia. Methods Thirty ASA physical statusⅠpediatric children, aged 9 months-1 yr, weighing 8.0-11.5 kg, undergoing elective laparoscopic hernia repair, were randomly assigned into 3 groups ( n=10 each) using a random number table: pressure control ventilation ( PCV) used for muscle relaxants in combination with low?concentration sevoflurane group ( group PCV1 ) , PCV used for high?concentration sevoflurane group ( group PCV2 ) , and PSV used for low?concentration sevoflurane group ( group PSV) . Anesthesia was induced with inhalation of 4%-6%sevoflurane and iv fentanyl 2 μg∕kg and succinylcholine 1.5 mg∕kg. The pediatric children were endotracheally intubated and mechanically ventilated. In PCV1 and PCV2 groups, PCV was used during operation. In group PSV, PCV was used first after intubation, and then PSV was applied after spontaneous breathing recovered. Anesthesia was maintained as follows: in group PCV1 , the end?tidal concentration of sevoflurane was maintained at 2.5% - 3.0%, and cisatracurium besylate 0.1 mg∕kg was injected intermittently as required; in group PCV1 , the end?tidal concentration of sevoflurane was maintained at 3.5%-4.0%; in group PSV, the end?tidal concentration of sevoflurane was maintained at 2.5%-3.0%, and succinylcholine 1.0 mg∕kg was injected intravenously before pneumoperitoneum. Narcotrend index value was maintained at 50-60 in PCV1 and PSV groups, or at 37-45 in PCV2 group. Heart rate ( HR) and mean arterial pressure (MAP) were recorded before induction of anesthesia (baseline), at the beginning of pneumoperitoneum, at 5 and 10 min of pneumoperitoneum, at the end of pneumoperitoneum, at the end of operation and immediately after extubation. The time interval from the end of surgery to extubation was recorded. Results Pulse oxygen saturation was 100% during anesthesia, and>95% during recovery from anesthesia in the three groups. Compared with the baseline value, HR was significantly faster, and MAP was increased during extubation in PCV1 and PCV2 groups, and no significant change was found in HR and MAP at each time point in group PSV. The time interval from the end of surgery to extubation was 30.3± 5.4, 18.4±4.3 and (4.1±1.2) min in PCV1, PCV2 and PSV groups, respectively. Compared with PCV1 and PCV2 groups, the time interval from the end of surgery to extubation was significantly shortened in group PSV. Conclusion When PSV is applied in the infants undergoing laparoscopic hernia repair under sevoflurane anesthesia, it can provide adequate ventilation, recovery from anesthesia is rapid, and no cardiovascular responses occur during extubation.